Test drug (T1): CBP-201 injection (pre-filled syringe, 150 mg/1 mL)
CBP-201-CN004
Phase 1 mab completed
Quick answer
Test drug (T1): CBP-201 injection (pre-filled syringe, 150 mg/1 mL) for Healthy Adult Subjects is a Phase 1 program (mab) at Connect Biopharma Holdings Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Connect Biopharma Holdings Ltd
- Indication
- Healthy Adult Subjects
- Phase
- Phase 1
- Modality
- mab
- Status
- completed